By Ross Marchand | Taxpayers Protection Alliance - April 06, 2021 at 01:00AM
Since the start of the pandemic, leading drug makers such as Pfizer, Moderna, AstraZeneca, and Johnson & Johnson have relied on robust intellectual property (IP) protections in developing coronavirus vaccines. Because of the patent protections afforded by developed countries such…
Read Entire Article Here: Watchdog National News
via IFTTT
